{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:41:37Z","timestamp":1792406497323,"version":"4.4.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["RGP.2 \/373 \/47"],"award-info":[{"award-number":["RGP.2 \/373 \/47"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tranon.2026.103080","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:20:42Z","timestamp":1792153242000},"page":"103080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cell-free DNA fragmentomics and epigenomic profiling in hematologic malignancies: current evidence, translational limitations, and future directions"],"prefix":"10.1016","volume":"74","author":[{"given":"Amr Ali Mohamed Abdelgawwad","family":"El-Sehrawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarmad S.","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guzalya","family":"Mamedova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasur","family":"Rizaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihab M.","family":"Abdelrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrey Kumar","family":"Srivastav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeina T.","family":"Khaleel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid S.","family":"Jabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Bainsal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseel","family":"Smerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.tranon.2026.103080_bib0001","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1158\/2159-8290.CD-21-1252","article-title":"The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer","volume":"13","author":"Mattox","year":"2023","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0002","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/s41467-024-46435-0","article-title":"Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology","volume":"15","author":"Stanley","year":"2024","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.tranon.2026.103080_bib0003","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1158\/1078-0432.CCR-24-3335","article-title":"Characterization of plasma cell-free DNA variants as of tumor or clonal hematopoiesis origin in 16,812 advanced cancer patients","volume":"31","author":"Magee","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00277-026-06741-7","article-title":"Portraits of clonal hematopoiesis in DNMT3A\/TET2\/ASXL1-mutant myelodysplastic neoplasms and acute myeloid leukemia","volume":"105","author":"Patel","year":"2026","journal-title":"Ann. Hematol."},{"issue":"19","key":"10.1016\/j.tranon.2026.103080_bib0005","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180065","article-title":"Clonal hematopoiesis and hematological malignancy","volume":"134","author":"Dunn","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.tranon.2026.103080_bib0006","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1158\/2643-3230.BCD-21-0143","article-title":"The cell type-specific 5hmC landscape and dynamics of healthy human hematopoiesis and TET2-mutant preleukemia","volume":"3","author":"Nakauchi","year":"2022","journal-title":"Blood Cancer Discov."},{"issue":"6","key":"10.1016\/j.tranon.2026.103080_bib0007","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1002\/jcp.30156","article-title":"IGF family effects on development, stability, and treatment of hematological malignancies","volume":"236","author":"Moonesi","year":"2021","journal-title":"J. Cell Physiol."},{"issue":"10","key":"10.1016\/j.tranon.2026.103080_bib0008","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1158\/1078-0432.CCR-22-3804","article-title":"A pre-leukemic DNA methylation signature in healthy individuals at higher risk for developing myeloid malignancy","volume":"30","author":"Lao","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.tranon.2026.103080_bib0009","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/bloodadvances.2019000175","article-title":"Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma","volume":"3","author":"Chiu","year":"2019","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13148-023-01547-0","article-title":"Cell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemia","volume":"15","author":"Shao","year":"2023","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.tranon.2026.103080_bib0011","article-title":"Cell-free chromatin state tracing reveals disease origin and therapy responses","author":"Chen","year":"2026","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0012","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41467-024-47195-7","article-title":"A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary","volume":"15","author":"Conway","year":"2024","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.tranon.2026.103080_bib0013","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.annonc.2023.06.001","article-title":"Fragmentomic analysis of circulating tumor DNA-targeted cancer panels","volume":"34","author":"Helzer","year":"2023","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.tranon.2026.103080_bib0014","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3390\/diagnostics12081834","article-title":"Tracing the origin of cell-free DNA molecules through tissue-specific epigenetic signatures","volume":"12","author":"Oberhofer","year":"2022","journal-title":"Diagnostics"},{"issue":"1-2","key":"10.1016\/j.tranon.2026.103080_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","article-title":"Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin","volume":"164","author":"Snyder","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2026.103080_bib0016","article-title":"Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers","volume":"14-2024","author":"Chang","year":"2024","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2026.103080_bib0017","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41568-025-00795-x","article-title":"Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection","volume":"25","author":"Bruhm","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.tranon.2026.103080_bib0018","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ccell.2025.09.006","article-title":"Cell-free DNA fragmentomics in cancer","volume":"43","author":"Tsui","year":"2025","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.tranon.2026.103080_bib0019","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41587-022-01222-4","article-title":"Inferring gene expression from cell-free DNA fragmentation profiles","volume":"40","author":"Esfahani","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tranon.2026.103080_bib0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1182\/blood-2021-150964","article-title":"Noninvasive cell-of-origin classification of diffuse large B-cell lymphoma using inferred gene expression from cell-free DNA sequencing","volume":"138","author":"Shahrokh Esfahani","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0021","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41408-024-01185-6","article-title":"High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis","volume":"14","author":"Martello","year":"2024","journal-title":"Blood Cancer J."},{"issue":"5","key":"10.1016\/j.tranon.2026.103080_bib0022","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/2159-8290.CD-19-0622","article-title":"Plasma DNA end-motif profiling as a fragmentomic marker in cancer, pregnancy, and transplantation","volume":"10","author":"Jiang","year":"2020","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.tranon.2026.103080_bib0023","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/ijms25021243","article-title":"Integration of cell-free DNA end motifs and fragment lengths can identify active genes in liquid biopsies","volume":"25","author":"Maansson","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.tranon.2026.103080_bib0024","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220982120","article-title":"Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs","volume":"120","author":"Zhou","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tranon.2026.103080_bib0025","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1182\/blood-2024-206636","article-title":"Cell-free DNA genomic and fragmentomic features for early outcome prediction in diffuse large B-cell lymphoma","volume":"144","author":"Wang","year":"2024","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.tranon.2026.103080_bib0026","article-title":"Holistic determination of ends of cfDNA molecules","volume":"6","author":"Jiang","year":"2026","journal-title":"Cell Genom."},{"issue":"8","key":"10.1016\/j.tranon.2026.103080_bib0027","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1101\/gr.261396.120","article-title":"Detection and characterization of jagged ends of double-stranded DNA in plasma","volume":"30","author":"Jiang","year":"2020","journal-title":"Genome Res."},{"issue":"7","key":"10.1016\/j.tranon.2026.103080_bib0028","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/clinchem\/hvac050","article-title":"Jagged ends on multinucleosomal cell-free DNA serve as a biomarker for nuclease activity and systemic lupus erythematosus","volume":"68","author":"Ding","year":"2022","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.tranon.2026.103080_bib0029","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.seminhematol.2023.06.004","article-title":"Cell-free DNA in large B-cell lymphoma: MRD and beyond","volume":"60","author":"Sworder","year":"2023","journal-title":"Semin. Hematol."},{"issue":"6","key":"10.1016\/j.tranon.2026.103080_bib0030","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/ahg.12210","article-title":"Evaluation of CCAAT\/enhancer binding protein (C\/EBP) alpha (CEBPA) and runt-related transcription factor 1 (RUNX1) expression in patients with De Novo acute myeloid leukemia","volume":"81","author":"Salarpour","year":"2017","journal-title":"Ann. Hum. Genet."},{"issue":"6","key":"10.1016\/j.tranon.2026.103080_bib0031","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/14737159.2025.2500659","article-title":"Circulating tumor DNA as a powerful tool in diagnostics and treatment outcome prediction\u2013focus on large B\u2013cell lymphomas and follicular lymphomas","volume":"25","author":"Hamova","year":"2025","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"3","key":"10.1016\/j.tranon.2026.103080_bib0032","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/leu.2016.243","article-title":"Loss of PRDM1\/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma","volume":"31","author":"Xia","year":"2017","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.tranon.2026.103080_bib0033","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.7150\/ijbs.92988","article-title":"The burgeoning significance of liquid-liquid phase separation in the pathogenesis and therapeutics of cancers","volume":"20","author":"Xu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tranon.2026.103080_bib0034","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-pathol-050520-044652","article-title":"Molecular monitoring of lymphomas","volume":"18","author":"Schroers-Martin","year":"2023","journal-title":"Annu. Rev. Pathol."},{"issue":"2","key":"10.1016\/j.tranon.2026.103080_bib0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.arcmed.2022.12.008","article-title":"Effect of acute myeloid leukemia-derived extracellular vesicles on bone marrow mesenchymal stromal cells: expression of poor prognosis genes","volume":"54","author":"Kargar-Sichani","year":"2023","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.tranon.2026.103080_bib0039","unstructured":"Wang, S., et al., Cell-free DNA genomic and fragmentomic features for early outcome prediction in large B-cell lymphoma. medRxiv, 2026: p. 2026.05.29.26353426. 10.64898\/2026.05.29.26353426."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0038","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ccell.2022.12.005","article-title":"Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas","volume":"41","author":"Sworder","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0036","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bjh.19916","article-title":"Chimeric antigen receptor copies in cell-free DNA predict relapse in aggressive B-cell lymphoma patients treated with CAR T-cell therapy","volume":"206","author":"de la Iglesia-San Sebasti\u00e1n","year":"2025","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.tranon.2026.103080_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113392","article-title":"Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies","volume":"144","author":"Sun","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41525-021-00179-8","article-title":"Alterations of 5-hydroxymethylation in circulating cell-free DNA reflect molecular distinctions of subtypes of non-Hodgkin lymphoma","volume":"6","author":"Chiu","year":"2021","journal-title":"npj Genom. Med."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170779","article-title":"Correlated 5-hydroxymethylcytosine (5hmC) and gene expression profiles underpin gene and organ-specific epigenetic regulation in adult mouse brain and liver","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.tranon.2026.103080_bib0042","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/gb-2011-12-6-r54","article-title":"5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells","volume":"12","author":"Stroud","year":"2011","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0043","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/s41467-024-46435-0","article-title":"Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology","volume":"15","author":"Stanley","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.tranon.2026.103080_bib0044","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3390\/genes14061180","article-title":"Classification of acute myeloid leukemia by cell-free DNA 5-hydroxymethylcytosine","volume":"14","author":"Shao","year":"2023","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16685-3","article-title":"Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia","volume":"12","author":"Shao","year":"2022","journal-title":"Sci. Rep."},{"issue":"6594","key":"10.1016\/j.tranon.2026.103080_bib0046","article-title":"The Tabula Sapiens: a multiple-organ, single-cell transcriptomic atlas of humans","volume":"376","author":"Jones","year":"2022","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.tranon.2026.103080_bib0047","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41587-021-01188-9","article-title":"Cell types of origin of the cell-free transcriptome","volume":"40","author":"Vorperian","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0048","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13148-020-00973-8","article-title":"5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diffuse large B cell lymphoma patients","volume":"13","author":"Chen","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.tranon.2026.103080_bib0049","first-page":"12","article-title":"5-Hydroxymethylcytosine profilings in circulating cell-free DNA as diagnostic biomarkers for DLBCL","author":"Chen","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.tranon.2026.103080_bib0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41389-019-0142-2","article-title":"Ibrutinib induces chromatin reorganisation of chronic lymphocytic leukaemia cells","volume":"8","author":"Holmes","year":"2019","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0051","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14756","article-title":"Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia","volume":"8","author":"Yeh","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.tranon.2026.103080_bib0052","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3324\/haematol.2022.282466","article-title":"Lymphocyte migration and retention properties affected by ibrutinib in chronic lymphocytic leukemia","volume":"109","author":"Rey-Barroso","year":"2024","journal-title":"Haematologica"},{"issue":"7943","key":"10.1016\/j.tranon.2026.103080_bib0053","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41586-022-05580-6","article-title":"A DNA methylation atlas of normal human cell types","volume":"613","author":"Loyfer","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0054","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1038\/s41467-018-07466-6","article-title":"Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease","volume":"9","author":"Moss","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0055","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.1038\/s41467-022-35320-3","article-title":"Tumor fractions deciphered from circulating cell-free DNA methylation for cancer early diagnosis","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0056","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13059-022-02710-1","article-title":"Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing","volume":"23","author":"Katsman","year":"2022","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.tranon.2026.103080_bib0057","article-title":"Cell type deconvolution of methylated cell-free DNA at the resolution of individual reads","volume":"5","author":"Keukeleire","year":"2023","journal-title":"NAR Genom. Bioinform."},{"issue":"9","key":"10.1016\/j.tranon.2026.103080_bib0058","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae522","article-title":"MetDecode: methylation-based deconvolution of cell-free DNA for noninvasive multi-cancer typing","volume":"40","author":"Passemiers","year":"2024","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0059","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41467-022-34642-6","article-title":"Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis","volume":"14","author":"Bros\u00e9us","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41375-021-01316-z","article-title":"Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patterns","volume":"36","author":"Bo\u017ei\u0107","year":"2022","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.tranon.2026.103080_bib0061","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/s41375-024-02300-z","article-title":"Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance","volume":"38","author":"McCarthy","year":"2024","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.tranon.2026.103080_bib0062","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood.2023022697","article-title":"Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantation","volume":"144","author":"Wienecke","year":"2024","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.tranon.2026.103080_bib0063","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1038\/s41588-025-02321-z","article-title":"Rapid epigenomic classification of acute leukemia","volume":"57","author":"Steinicke","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tranon.2026.103080_bib0064","article-title":"Genome-wide methylation profiling of peripheral T-cell lymphomas identifies TRIP13 as a critical driver of tumor proliferation and survival","author":"Nowialis","year":"2024","journal-title":"Res. Sq."},{"issue":"8_Supplement","key":"10.1016\/j.tranon.2026.103080_bib0065","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1158\/1538-7445.AM2012-2997","article-title":"Peripheral T-cell lymphomas not otherwise specified correspond to distinct mature T-cell populations basing on the global gene expression profile","volume":"72","author":"Piccaluga","year":"2012","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.tranon.2026.103080_bib0066","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1182\/bloodadvances.2021005171","article-title":"Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers","volume":"5","author":"Rodr\u00edguez","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.tranon.2026.103080_bib0067","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hon.120_2629","article-title":"New data In the molecular pathology of T-cell lymphomas","volume":"37","author":"De Leval","year":"2019","journal-title":"Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2026.103080_bib0068","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/life12030410","article-title":"Genetic landscape of peripheral T-cell lymphoma","volume":"12","author":"Hathuc","year":"2022","journal-title":"Life"},{"issue":"12","key":"10.1016\/j.tranon.2026.103080_bib0069","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2014.83","article-title":"Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice","volume":"4","author":"Muto","year":"2014","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0070","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.1038\/s41467-024-52826-0","article-title":"Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas","volume":"15","author":"Fischer","year":"2024","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.tranon.2026.103080_bib0071","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood.2021015019","article-title":"DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS","volume":"140","author":"Herek","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0072","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1038\/s41467-023-41774-w","article-title":"Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization","volume":"14","author":"Bie","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0073","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41467-024-55428-y","article-title":"Multimodal cell-free DNA whole-genome TAPS is sensitive and reveals specific cancer signals","volume":"16","author":"Vavoulis","year":"2025","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.tranon.2026.103080_bib0074","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41568-026-00939-7","article-title":"Tracing disease origin with plasma cell-free chromatin","volume":"26","author":"Meng","year":"2026","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13059-024-03456-8","article-title":"Systematic evaluation of methylation-based cell type deconvolution methods for plasma cell-free DNA","volume":"25","author":"Sun","year":"2024","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.tranon.2026.103080_bib0076","first-page":"1060","article-title":"Evaluation of ATG7 and light Chain 3 (LC3) autophagy genes expression in AML patients","volume":"18","author":"Mohamadimaram","year":"2019","journal-title":"Iran. J. Pharm. Res."},{"issue":"19","key":"10.1016\/j.tranon.2026.103080_bib0077","doi-asserted-by":"crossref","DOI":"10.3390\/cells11192939","article-title":"Locus-specific enrichment analysis of 5-hydroxymethylcytosine reveals novel genes associated with breast carcinogenesis","volume":"11","author":"Ramasamy","year":"2022","journal-title":"Cells"},{"issue":"44","key":"10.1016\/j.tranon.2026.103080_bib0078","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209852119","article-title":"Epigenetic analysis of cell-free DNA by fragmentomic profiling","volume":"119","author":"Zhou","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0079","article-title":"Cell-free DNA analysis for cancer management: technologies, features, and clinical translation","volume":"1","author":"Zhu","year":"2026","journal-title":"Mol. Digit. Med."},{"issue":"466","key":"10.1016\/j.tranon.2026.103080_bib0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tranon.2026.103080_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101694","article-title":"Integrated fragmentomic profile and 5-hydroxymethylcytosine of capture-based low-pass sequencing data enables pan-cancer detection via cfDNA","volume":"34","author":"Zhang","year":"2023","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0082","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13148-021-01182-7","article-title":"Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA","volume":"13","author":"Kerachian","year":"2021","journal-title":"Clin. Epigenetics"},{"issue":"11","key":"10.1016\/j.tranon.2026.103080_bib0083","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166354","article-title":"Performance of streck cfDNA blood collection tubes for liquid biopsy testing","volume":"11","author":"Medina Diaz","year":"2016","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.tranon.2026.103080_bib0084","doi-asserted-by":"crossref","first-page":"7880","DOI":"10.3390\/molecules28237880","article-title":"Mass spectrometric detection of formaldehyde-crosslinked PBMC proteins in cell-free DNA blood collection tubes","volume":"28","author":"R\u00f6th","year":"2023","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.tranon.2026.103080_bib0085","doi-asserted-by":"crossref","DOI":"10.3390\/biom14111346","article-title":"Methods for detection and mapping of methylated and hydroxymethylated cytosine in DNA","volume":"14","author":"Kisil","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0086","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/17501911.2025.2586452","article-title":"5mC and 5hmC methylation sequencing: the power of 6-base sequencing in a multiomic era","volume":"18","author":"Crawford","year":"2026","journal-title":"Epigenomics"},{"issue":"2","key":"10.1016\/j.tranon.2026.103080_bib0087","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1158\/1078-0432.CCR-23-0730","article-title":"Detection of recurrence through microRNA-371a-3p serum levels in a follow-up of stage I testicular germ cell tumors in the DRKS-00019223 study","volume":"30","author":"Belge","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0088","doi-asserted-by":"crossref","DOI":"10.1093\/bioadv\/vbaf108","article-title":"cfTools: an R\/bioconductor package for deconvolving cell-free DNA via methylation analysis","volume":"5","author":"Hu","year":"2025","journal-title":"Bioinform. Adv."},{"issue":"16","key":"10.1016\/j.tranon.2026.103080_bib0089","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1093\/bioinformatics\/btaa999","article-title":"FinaleDB: a browser and database of cell-free DNA fragmentation patterns","volume":"37","author":"Zheng","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tranon.2026.103080_bib0090","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.csbj.2021.06.030","article-title":"Integration strategies of multi-omics data for machine learning analysis","volume":"19","author":"Picard","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0091","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13073-023-01178-3","article-title":"Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing","volume":"15","author":"Lau","year":"2023","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0092","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70174","article-title":"Integrating multi-omics features enables non-invasive early diagnosis and treatment response prediction of diffuse large B-cell lymphoma","volume":"15","author":"Zhang","year":"2025","journal-title":"Clin. Transl. Med."},{"issue":"7","key":"10.1016\/j.tranon.2026.103080_bib0093","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/15592294.2020.1827714","article-title":"Genome-wide study of the effect of blood collection tubes on the cell-free DNA methylome","volume":"16","author":"Van Paemel","year":"2021","journal-title":"Epigenetics"},{"issue":"7","key":"10.1016\/j.tranon.2026.103080_bib0094","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13071288","article-title":"Pre-analytical evaluation of streck cell-free DNA blood collection tubes for liquid profiling in oncology","volume":"13","author":"Diaz","year":"2023","journal-title":"Diagnostics"},{"issue":"18","key":"10.1016\/j.tranon.2026.103080_bib0095","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.clinbiochem.2016.03.012","article-title":"Comparative analysis of circulating tumor DNA stability In K(3)EDTA, Streck, and CellSave blood collection tubes","volume":"49","author":"Kang","year":"2016","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0096","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1038\/s41467-022-32995-6","article-title":"Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer","volume":"13","author":"Stackpole","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.tranon.2026.103080_bib0097","article-title":"Sensitive and reproducible cell-free methylome quantification with synthetic spike-in controls","volume":"2","author":"Wilson","year":"2022","journal-title":"Cell Rep. Methods"},{"issue":"7","key":"10.1016\/j.tranon.2026.103080_bib0098","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad423","article-title":"MEDIPIPE: an automated and comprehensive pipeline for cfMeDIP-seq data quality control and analysis","volume":"39","author":"Zeng","year":"2023","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0099","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41467-021-20920-2","article-title":"Subtraction-free and bisulfite-free specific sequencing of 5-methylcytosine and its oxidized derivatives at base resolution","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.103080_bib0100","doi-asserted-by":"crossref","DOI":"10.1038\/srep27859","article-title":"Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma","volume":"6","author":"Burnham","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.tranon.2026.103080_bib0101","article-title":"Single-stranded DNA library preparation from highly degraded DNA using T4 DNA ligase","volume":"45","author":"Gansauge","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0102","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1186\/s12864-019-6355-0","article-title":"A ligation-based single-stranded library preparation method to analyze cell-free DNA and synthetic oligos","volume":"20","author":"Troll","year":"2019","journal-title":"BMC Genom."},{"issue":"2","key":"10.1016\/j.tranon.2026.103080_bib0103","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/clinchem\/hvac180","article-title":"Comparison of single molecule, real-time sequencing and nanopore sequencing for analysis of the size, end-motif, and tissue-of-origin of long cell-free DNA in plasma","volume":"69","author":"Yu","year":"2023","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.tranon.2026.103080_bib0104","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ng.3805","article-title":"Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA","volume":"49","author":"Guo","year":"2017","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0105","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41420-025-02828-8","article-title":"Nanopore sequencing enables tissue-of-origin and pathogen detection in plasma cell-free DNA from critically ill patients","volume":"11","author":"Willemart","year":"2025","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0106","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s13059-021-02510-z","article-title":"DNA methylation-calling tools for Oxford Nanopore sequencing: a survey and human epigenome-wide evaluation","volume":"22","author":"Liu","year":"2021","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.tranon.2026.103080_bib0107","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3324\/haematol.2019.241208","article-title":"Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas","volume":"106","author":"Bobillo","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0108","first-page":"vdaf208","article-title":"New biomarkers for the diagnosis of primary central nervous system lymphoma in CSF: a multicenter retrospective cohort study","volume":"7","author":"van Rooij","year":"2025","journal-title":"Neurooncol. Adv."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0109","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/s41467-025-60507-9","article-title":"Circulating cell-free DNA methylation patterns indicate cellular sources of allograft injury after liver transplant","volume":"16","author":"McNamara","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.tranon.2026.103080_bib0110","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41556-024-01358-2","article-title":"Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entities","volume":"26","author":"Roider","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"23","key":"10.1016\/j.tranon.2026.103080_bib0111","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300445","article-title":"Cellular composition and 5hmC signature predict the treatment response of AML patients to azacitidine combined with chemotherapy","volume":"10","author":"Liang","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2026.103080_bib0112","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1038\/s41467-025-59796-x","article-title":"Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs","volume":"16","author":"Thoms","year":"2025","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.tranon.2026.103080_bib0113","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1016\/j.clml.2025.05.003","article-title":"Minimal residual disease testing for diffuse large B cell lymphoma","volume":"25","author":"Atout","year":"2025","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"8","key":"10.1016\/j.tranon.2026.103080_bib0114","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41408-018-0111-6","article-title":"Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort","volume":"8","author":"Bohers","year":"2018","journal-title":"Blood Cancer J."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332600416X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332600416X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:51:59Z","timestamp":1792403519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193652332600416X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":114,"alternative-id":["S193652332600416X"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103080","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-free DNA fragmentomics and epigenomic profiling in hematologic malignancies: current evidence, translational limitations, and future directions","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103080"}}